|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Vesicare (Solifenacin). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (527)
Cases resulting in a serious event (188)
Cases resulting in death (12)
Cases resulting in life threatening events (10)
Cases resulting in hospitalization (74)
Cases resulting in disability (16)
Cases resulting in other serious reactions (99)
Below is a sample of reports where side effects / adverse reactions may be related to Vesicare (Solifenacin). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 68 year old female receiving Vesicare (Solifenacin)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 68 year old female
Adverse reactions / side effects: Drug Ineffective, Heart Rate Increased, Condition Aggravated, Cystitis, Heart Rate Irregular, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Insulin Novolin 70 / 30 (Insulin Human Semisynthetic, Insulin Isophane H; Glucophage; Norvasc; Coreg; Clonidine; Nexium; Zoloft; Topamax; Hydrochlorothiazide; Aspirin; Multi-Vitamin; Adalat; Cozaar
Adverse event in female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-24
Patient: female, weighing 46.5 kg (102.3 pounds)
Adverse reactions / side effects: Sick Sinus Syndrome, Hyperkalaemia
Adverse event resulted in: life threatening event
Suspect drug(s):
Enalapril Maleate
Administration route: Oral
Indication: Hypertension
Start date: 2006-04-26
Micardis
Administration route: Oral
Indication: Hypertension
Start date: 2003-01-14
End date: 2007-08-19
Spironolactone
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2007-08-01
End date: 2007-08-19
Vesicare
Administration route: Oral
Indication: Hypertonic Bladder
Start date: 2007-02-21
End date: 2007-08-19
Other drugs received by patient: Herpamine (Denopamine); Diart; Promac (Polaprezinc); Goodmin; Minzain
Adverse event in 74 year old male receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-23
Patient: 74 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Haemoptysis, Condition Aggravated
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Prednisolone; Baktar (Sulfamethoxazole, Trimethoprim) Tablet; Omeprazole
Adverse event in female receiving Vesicare (Solifenacin)
Reported by a physician from Spain on 2007-10-23
Patient: female
Adverse reactions / side effects: Parkinson's Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Adverse event in 75 year old female receiving Vesicare (Solifenacin)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: 75 year old female
Adverse reactions / side effects: Agitation, Dyspnoea, Vaginal Abscess, Musculoskeletal Discomfort, Vaginal Haemorrhage, Palpitations, Vision Blurred, Toothache, Urinary Retention, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Atenolol; Altace; Glimepiride; Gabapentin; Multivitamins (Ergocalciferol Folic Acid, Nicotinamide, Panthenol, THI
Adverse event in 71 year old male receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-23
Patient: 71 year old male, weighing 73.4 kg (161.5 pounds)
Adverse reactions / side effects: Erythema Multiforme
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Bayaspirin Tablets; Amaryl; Amlodipine Besylate; Diovan; Urso 250
Adverse event in 81 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-19
Patient: 81 year old female, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Torsade DE Pointes
Adverse event resulted in: life threatening event
Suspect drug(s):
Vesicare
Dosage: 5 mg, uid/qd, oral; oral
Administration route: Oral
Start date: 2007-01-01
End date: 2007-01-01
Vesicare
Dosage: 5 mg, uid/qd, oral; oral
Administration route: Oral
Start date: 2007-02-28
End date: 2007-03-28
Other drugs received by patient: Spiropent (Clenbuterol Hydrochloride); Amlodipine Besylate; Alfarol (Alfacalcidol); Gasport; Strocain (Oxetacaine); Selbex (Teprenone); Marzulene S (Levoglutamide, Sodium Gualenate); Meilax (Ethyl Loflazepate); Cefazolin; Vancomycin; Targocid
Adverse event in 76 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-19
Patient: 76 year old female, weighing 39.8 kg (87.6 pounds)
Adverse reactions / side effects: Dehydration, Incorrect Dose Administered, Dizziness, Blood Pressure Decreased
Suspect drug(s):
Carvedilol
Dosage: 2.5 mg, uid/qd, oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-26
End date: 2007-07-31
Vesicare
Dosage: 2.5 mg, uid/qd, oral
Administration route: Oral
Indication: Hypertonic Bladder
Other drugs received by patient: Rhythmy (Rilmazafone); Aspirin; Sigmart (Nicorandil); Lansoprazole; Risedronate Sodium; Amlodipine Besylate; Selbex (Teprenone); Isosorbide Mononitrate
Adverse event in 32 year old female receiving Vesicare (Solifenacin)
Reported by a individual with unspecified qualification from United States on 2007-10-18
Patient: 32 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Blighted Ovum, Abortion Spontaneous, Pregnancy
Suspect drug(s):
Baclofen
Indication: Muscle Spasms
End date: 2007-03-01
Celexa
Indication: Depression
End date: 2007-03-01
Dynacin
Indication: Sweat Gland Infection
End date: 2007-03-01
Provigil
Indication: Fatigue
End date: 2007-03-01
Rebif
Dosage: 44 mcg/3 times wkly/sc
Indication: Multiple Sclerosis
Start date: 2006-03-14
End date: 2007-03-01
Relpax
Dosage: prn
Indication: Migraine
End date: 2007-03-01
Seroquel
Indication: Insomnia
End date: 2007-03-01
Vesicare
Indication: Bladder Disorder
End date: 2007-03-01
Adverse event in 32 year old female receiving Vesicare (Solifenacin)
Reported by a consumer/non-health professional from United States on 2007-10-15
Patient: 32 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous
Suspect drug(s):
Baclofen
Indication: Muscle Spasms
End date: 2007-03-01
Celexa
Indication: Depression
End date: 2007-03-01
Minocycline(minocycline Hydrochloride
Indication: Sweat Gland Infection
End date: 2007-03-01
Provigil
Indication: Fatigue
End date: 2007-03-01
Rebif
Dosage: 44 other, subcutaneous
Indication: Multiple Sclerosis
Start date: 2006-03-14
End date: 2007-03-01
Relpax
Indication: Migraine
End date: 2007-03-01
Seroquel
Indication: Insomnia
End date: 2007-03-01
Vesicare
Indication: Urinary Tract Disorder
End date: 2007-03-01
Adverse event in 87 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 87 year old female, weighing 30.5 kg (67.1 pounds)
Adverse reactions / side effects: Cystitis Noninfective, Urinary Bladder Haemorrhage
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Bufferin (Aluminium Glycinate) Tablet; Aspara (Aspartate Potassium) Tablet; Depas (Etizolam) Tablet; Persantin (Dipyridamole) Tablet; Gasmotin (Mosapride Citrate) Tablet; Lendormin (Brotizolam) Tablet; Magnesium Oxide (Magnesium Oxide) Powder
Adverse event in 83 year old male receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 83 year old male
Adverse reactions / side effects: Cardiac Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Candesartan Cilexetil; Piclonadine (Ticlopidine Hydrochloride); Propafenone HCL; Hibon (Riboflavin Tetrabutyrate); Sigmart (Nicorandil); Diltiazem Hydrochloride; Pursennid (Sennoside A+b); Isosorbide Dinitrate; Urief
Adverse event in 85 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 85 year old female
Adverse reactions / side effects: Rhabdomyolysis, Conjunctival Hyperaemia, Parkinsonism, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Gramilil(tiapride Hydrochloride) Tablet, 25mg
Dosage: 25 mg, bid, oral
Administration route: Oral
Indication: Cerebral Infarction
Start date: 2007-06-08
End date: 2007-08-03
Paxil
Dosage: 10 mg, uid/qd, oral
Administration route: Oral
Indication: Depression
Start date: 2007-06-04
End date: 2007-06-11
Vesicare
Dosage: 2.5 mg, oral; 2.5 mg, oral
Administration route: Oral
Indication: Hypertonic Bladder
Start date: 2007-06-04
End date: 2007-06-01
Vesicare
Dosage: 2.5 mg, oral; 2.5 mg, oral
Administration route: Oral
Indication: Hypertonic Bladder
Start date: 2007-07-09
End date: 2007-08-03
Other drugs received by patient: Bufferin (Aluminium Glycinate) Tablet; Epadel (Ethyl Icosapentate) PER Oral NOS; Impromen (Bromperidol) Tablet; Alfarol (Alfacalcidol) Capsule; Gefanil (Gefarnate) Capsule; Pursennid (Sennoside A+b) Tablet; Adofeed (Flurbiprofen) Formulation Unknown; Ibuprofen Granule; Kitazemin (Mequitazine) Fine Granule; Marzulene S (Levoglutamide, Sodium Gualenate) Granule; Flomox (Cefcapene Pivoxil Hydrochloride) Tablet; Selbex (Teprenone) Fine Granule
Adverse event in 83 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 83 year old female
Adverse reactions / side effects: Atrioventricular Block Complete
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Aricept; Rize (Clotiazepam) Tablet
Adverse event in 71 year old male receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 71 year old male, weighing 73.4 kg (161.5 pounds)
Adverse reactions / side effects: Erythema Multiforme
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Bayaspirin Tablet; Amaryl; Amlodin (Amlodipine Besilate) Tablet; Diovan; Urso (Ursodeoxycholic Acid) Tablet
Adverse event in 90 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-09
Patient: 90 year old female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Dementia, Parkinsonism
Suspect drug(s):
Aricept
Dosage: 5 mg, uid/qd, oral; 5 mg/d, oral
Administration route: Oral
Indication: Dementia
Start date: 2004-07-09
End date: 2007-07-21
Aricept
Dosage: 5 mg, uid/qd, oral; 5 mg/d, oral
Administration route: Oral
Indication: Dementia
Start date: 2007-08-08
Paxil
Dosage: 20 mg, bid, oral
Administration route: Oral
Indication: Depression
Start date: 2005-09-07
End date: 2007-07-21
Vesicare
Dosage: 5 mg, uid/qd, oral; 10 mg, uid/qd,
Indication: Hypertonic Bladder
Start date: 2007-06-20
End date: 2007-07-03
Vesicare
Dosage: 5 mg, uid/qd, oral; 10 mg, uid/qd,
Indication: Hypertonic Bladder
Start date: 2007-07-04
End date: 2007-07-21
Other drugs received by patient: Calblock (Azelnidipine) Tablet; Tenormin; Blopress (Candesartan Cilexetil) Tablet
Adverse event in 75 year old female receiving Vesicare (Solifenacin)
Reported by a physician from United States on 2007-10-09
Patient: 75 year old female
Adverse reactions / side effects: Agitation, Dyspnoea, Vaginal Abscess, Musculoskeletal Discomfort, Vaginal Haemorrhage, Palpitations, Vision Blurred, Toothache, Urinary Retention, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Metformin (Metformin Hydrochloride); Glimepiride; Gabapentin; Multivitamins (Ergocalciferol, Folic Acid, Nicotinamide, Panthenol, TH; Atenolol; Altace
Adverse event in 76 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-10-03
Patient: 76 year old female, weighing 39.8 kg (87.6 pounds)
Adverse reactions / side effects: Dehydration, Procedural Dizziness, Blood Pressure Decreased
Suspect drug(s):
Artist (Carvedilol) Tablet
Dosage: 2.5 mg, uid/qd, oral
Start date: 2007-07-26
End date: 2007-07-31
Vesicare
Dosage: 2.5 mg, uid/qd, oral
Administration route: Oral
Indication: Hypertonic Bladder
Other drugs received by patient: Rhythmy (Rilmazafone) Tablet; Bayaspirin Tablet; Sigmart (Nicorandil) Tablet; Takepron (Lansoprazole) Tablet; Benet (Risedronate Sodium) Tablet; Amlodipine Besylate; Selbex (Teprenone); Isosorbide Mononitrate
Adverse event in female receiving Vesicare (Solifenacin)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Baclofen
Indication: Muscle Spasms
Celexa
Indication: Depression
Minocycline HCL
Indication: Sweat Gland Infection
Provigil
Indication: Fatigue
Rebif
Indication: Multiple Sclerosis
Start date: 2006-03-14
End date: 2007-03-01
Relpax
Indication: Migraine
Seroquel
Indication: Insomnia
Vesicare
Indication: Bladder Disorder
Adverse event in 75 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-07-30
Patient: 75 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Rectal Ulcer, Anaphylactic Shock, Feeling Abnormal, Treatment Noncompliance
Adverse event resulted in: life threatening event
Suspect drug(s):
Choreitou(herbal Extract Nos) Granule
Dosage: 2.5 mg, tid, oral
Administration route: Oral
Indication: Pollakiuria
Start date: 2007-06-22
End date: 2007-06-22
Vesicare
Dosage: 5 mg, uid/qd, oral
Administration route: Oral
Indication: Pollakiuria
Start date: 2007-06-22
End date: 2007-06-22
Adverse event in male receiving Vesicare (Solifenacin)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-07-26
Patient: male
Adverse reactions / side effects: Cognitive Disorder
Suspect drug(s):
Vesicare (Solifenacin)
Adverse event in 84 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-07-26
Patient: 84 year old female, weighing 71.0 kg (156.2 pounds)
Adverse reactions / side effects: Urinary Retention, Pyrexia, Upper Respiratory Tract Inflammation
Adverse event resulted in: hospitalization
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Gaster D Orodispersable CR Tablet; Lipitor; Amlodipine Besylate; Aspirin; Blopress (Candesartan Cilexetil); Lasix; Alfarol (Alfacalcidol)
Adverse event in 75 year old female receiving Vesicare (Solifenacin)
Reported by a physician from Japan on 2007-07-23
Patient: 75 year old female
Adverse reactions / side effects: Rectal Ulcer, Anaphylactic Shock, Feeling Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Choreitou(herbal Extract Nos) PER Oral NOS
Dosage: 7.5 mg, /d, oral
Administration route: Oral
Indication: Pollakiuria
Start date: 2007-06-22
End date: 2007-06-22
Vesicare
Dosage: 5 mg, /d, oral
Indication: Pollakiuria
Start date: 2007-06-22
End date: 2007-06-22
Adverse event in 70 year old female receiving Vesicare (Solifenacin)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-23
Patient: 70 year old female
Adverse reactions / side effects: Dizziness, Fall
Suspect drug(s):
Vesicare (Solifenacin)
Other drugs received by patient: Aspirin; Codeine Phosphate and Acetaminophen; Gastrocote (Sodium Bicarbonate, Aluminium Hydroxide Gel, Dried, Magnes; Levothyroxine Sodium; Mirtazapine; Omeprazole; Valsartan
Adverse event in 38 year old female receiving Vesicare (Solifenacin)
Reported by a physician from United Kingdom on 2007-07-20
Patient: 38 year old female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Chest Pain, DRY Throat, Paraesthesia
Suspect drug(s):
Vesicare (Solifenacin)
|
